The DOI matches its Crossref record; 142 of the 142 references it cites were found in a registry or an index.
Carcinoma-associated fibroblasts: orchestrating the composition of malignancy
Open accessAbstract
The tumor stroma is no longer seen solely as physical support for mutated epithelial cells but as an important modulator and even a driver of tumorigenicity. Within the tumor stromal milieu, heterogeneous populations of fibroblast-like cells, collectively termed carcinoma-associated fibroblasts (CAFs), are key players in the multicellular, stromal-dependent alterations that contribute to malignant initiation and progression. This review focuses on novel insights into the contributions of CAFs to disease progression, emergent events leading to the generation of CAFs, identification of CAF-specific biomarkers predictive of disease outcome, and recent therapeutic approaches aimed at blunting or reverting detrimental protumorigenic phenotypes associated with CAFs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
Eisenhauer, E. A., Therasse, P., Bogaerts, J., Schwartz, L. H., Sargent, D., Ford, R., Dancey, J., Arbuck, S., Gwyther, S., Mooney, M., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.10.026 · Cited by 29,534
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
Influence of tumour micro-environment heterogeneity on therapeutic response
Junttila, M. R., & de Sauvage, F. J. (2013) · Nature · doi:10.1038/nature12626 · Cited by 2,694
Özdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C.-C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.005 · Cited by 2,681
Feig, C., Jones, J. O., Kraman, M., Wells, R. J. B., Deonarine, A., Chan, D. S., Connell, C. M., Roberts, E. W., Zhao, Q., Caballero, O. L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320318110 · Cited by 2,100 · cited 1×
“As predicted, a CXCL12 receptor inhibitor synergized with α-CTLA-4 and α-PD-L1 to clear cancer cells (Feig et al. 2013).”
BackgroundStromal gene expression predicts clinical outcome in breast cancer
Finak, G., Bertos, N., Pepin, F., Sadekova, S., Souleimanova, M., Zhao, H., Chen, H., Omeroglu, G., Meterissian, S., Omeroglu, A., et al. (2008) · Nature Medicine · doi:10.1038/nm1764 · Cited by 1,687
Bissell, M. J., & Hines, W. C. (2011) · Nature Medicine · doi:10.1038/nm.2328 · Cited by 1,517
Erez, N., Truitt, M., Olson, P., & Hanahan, D. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.041 · Cited by 1,515
Carcinoma-associated fibroblasts stimulate tumor progression of initiated human epithelium
Olumi, A., Grossfeld, G., Hayward, S., Carroll, P., Cunha, G., Hein, P., & Tlsty, T. (2000) · Breast Cancer Research · doi:10.1186/bcr138 · Cited by 1,463
Self-citationTGF-ß Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia
Bhowmick, N. A., Chytil, A., Plieth, D., Gorska, A. E., Dumont, N., Shappell, S., Washington, M. K., Neilson, E. G., & Moses, H. L. (2004) · Science · doi:10.1126/science.1090922 · Cited by 1,401
Hallmarks of cancer: Interactions with the tumor stroma
Pietras, K., & Östman, A. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.02.045 · Cited by 1,141
CD36, a Scavenger Receptor Involved in Immunity, Metabolism, Angiogenesis, and Behavior
Silverstein, R. L., & Febbraio, M. (2009) · Science Signaling · doi:10.1126/scisignal.272re3 · Cited by 1,141
Quante, M., Tu, S. P., Tomita, H., Gonda, T., Wang, S. S. W., Takashi, S., Baik, G. H., Shibata, W., DiPrete, B., Betz, K. S., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.01.020 · Cited by 1,044
Discovery of Endothelial to Mesenchymal Transition as a Source for Carcinoma-Associated Fibroblasts
Zeisberg, E. M., Potenta, S., Xie, L., Zeisberg, M., & Kalluri, R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-3127 · Cited by 1,011
TUMOR STROMA AND REGULATION OF CANCER DEVELOPMENT
Tlsty, T. D., & Coussens, L. M. (2006) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100224 · Cited by 987
Self-citationChang, H. Y., Nuyten, D. S. A., Sneddon, J. B., Hastie, T., Tibshirani, R., Sørlie, T., Dai, H., He, Y. D., van't Veer, L. J., Bartelink, H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409462102 · Cited by 981
A paracrine requirement for hedgehog signalling in cancer
Yauch, R. L., Gould, S. E., Scales, S. J., Tang, T., Tian, H., Ahn, C. P., Marshall, D., Fu, L., Januario, T., Kallop, D., et al. (2008) · Nature · doi:10.1038/nature07275 · Cited by 961
Chang, H. Y., Sneddon, J. B., Alizadeh, A. A., Sood, R., West, R. B., Montgomery, K., Chi, J.-T., Rijn, M. V. D., Botstein, D., & Brown, P. O. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020007 · Cited by 951
Fibroblast heterogeneity in the cancer wound
Öhlund, D., Elyada, E., & Tuveson, D. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20140692 · Cited by 926
Environment-mediated drug resistance: A major contributor to minimal residual disease
Meads, M. B., Gatenby, R. A., & Dalton, W. S. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2714 · Cited by 892
New horizons in tumor microenvironment biology: challenges and opportunities
Chen, F., Zhuang, X., Lin, L., Yu, P., Wang, Y., Shi, Y., Hu, G., & Sun, Y. (2015) · BMC Medicine · doi:10.1186/s12916-015-0278-7 · Cited by 704 · cited 3×
“…2011; Lecomte et al. 2012; McDonald et al. 2015), adipocytes (Bochet et al. 2013), endothelial cells (Zeisberg et al. 2007), or even, perhaps, epithelial cells (Radisky et al. 2007) that undergo mesenchymal transition when instructed by systemic factors secreted by the tumor (Chen et al. 2015a).”
BackgroundIdentification of fibroblast heterogeneity in the tumor microenvironment
Sugimoto, H., Mundel, T. M., Kieran, M. W., & Kalluri, R. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.12.3354 · Cited by 699
Cancer associated fibroblasts: the dark side of the coin.
Cirri, P., & Chiarugi, P. (2011) · Europe PMC (PubMed Central) · Cited by 654
Loeffler, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26532 · Cited by 633 · cited 1×
“Although antibodies targeting FAP are promising candidate drugs in animal models (Loeffler et al. 2006; Ostermann et al. 2008), clinical trials assessing twoantibodies (Table2)havenot shown the expected efficacy (Hofheinz et al. 2003).”
BackgroundGene expression profiling of the tumor microenvironment during breast cancer progression
Ma, X.-J., Dahiya, S., Richardson, E., Erlander, M., & Sgroi, D. C. (2009) · Breast Cancer Research · doi:10.1186/bcr2222 · Cited by 629
Cancer-associated fibroblasts and tumor growth – bystanders turning into key players
Östman, A., & Augsten, M. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.01.003 · Cited by 543
Barcellos‐Hoff, M. H., & Ravani, S. A. (2000) · PubMed · Cited by 536
Bochet, L., Lehuédé, C., Dauvillier, S., Wang, Y. Y., Dirat, B., Laurent, V., Dray, C., Guiet, R., Maridonneau-Parini, I., Le Gonidec, S., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0530 · Cited by 529
Karagiannis, G. S., Poutahidis, T., Erdman, S. E., Kirsch, R., Riddell, R. H., & Diamandis, E. P. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0307 · Cited by 507
Regulation of In Situ to Invasive Breast Carcinoma Transition
Hu, M., Yao, J., Carroll, D. K., Weremowicz, S., Chen, H., Carrasco, D., Richardson, A., Violette, S., Nikolskaya, T., Nikolsky, Y., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.03.007 · Cited by 502
Pietras, K., Pahler, J., Bergers, G., & Hanahan, D. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050019 · Cited by 453
Rønnov-Jessen, L., Petersen, O. W., Koteliansky, V. E., & Bissell, M. J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117736 · Cited by 444
Liao, D., Luo, Y., Markowitz, D., Xiang, R., & Reisfeld, R. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007965 · Cited by 437 · cited 1×
“Indeed, interactions of CAFs with cellular components of the immune system contribute, to a large extent, to the tumor-promoting role of CAFs through immunosuppression and sustained inflammation (Liao et al. 2009; Erez et al. 2010; Quante et al. 2011; Servais and Erez 2013).”
BackgroundIshii, G., Ochiai, A., & Neri, S. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.07.007 · Cited by 434
Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice
Santos, A. M., Jung, J., Aziz, N., Kissil, J. L., & Puré, E. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38988 · Cited by 428
Cancer-Associated Fibroblasts as Another Polarized Cell Type of the Tumor Microenvironment
Augsten, M. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00062 · Cited by 427
Selection of Bone Metastasis Seeds by Mesenchymal Signals in the Primary Tumor Stroma
Zhang, X. H.-F., Jin, X., Malladi, S., Zou, Y., Wen, Y. H., Brogi, E., Smid, M., Foekens, J. A., & Massagué, J. (2013) · Cell · doi:10.1016/j.cell.2013.07.036 · Cited by 425
The stroma as a crucial target in rat mammary gland carcinogenesis
Maffini, M. V., Soto, A. M., Calabro, J. M., Ucci, A. A., & Sonnenschein, C. (2004) · Journal of Cell Science · doi:10.1242/jcs.01000 · Cited by 416
The Reprogramming of Tumor Stroma by HSF1 Is a Potent Enabler of Malignancy
Scherz-Shouval, R., Santagata, S., Mendillo, M. L., Sholl, L. M., Ben-Aharon, I., Beck, A. H., Dias-Santagata, D., Koeva, M., Stemmer, S. M., Whitesell, L., et al. (2014) · Cell · doi:10.1016/j.cell.2014.05.045 · Cited by 386
Lyons, T. R., O'Brien, J., Borges, V. F., Conklin, M. W., Keely, P. J., Eliceiri, K. W., Marusyk, A., Tan, A.-C., & Schedin, P. (2011) · Nature Medicine · doi:10.1038/nm.2416 · Cited by 380
Hofheinz, R.-D., al-Batran, S.-E., Hartmann, F., Hartung, G., Jäger, D., Renner, C., Tanswell, P., Kunz, U., Amelsberg, A., Kuthan, H., et al. (2003) · Oncology Research and Treatment · doi:10.1159/000069863 · Cited by 374
MicroRNAs Reprogram Normal Fibroblasts into Cancer-Associated Fibroblasts in Ovarian Cancer
Mitra, A. K., Zillhardt, M., Hua, Y., Tiwari, P., Murmann, A. E., Peter, M. E., & Lengyel, E. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0206 · Cited by 371
Albrengues, J., Bertero, T., Grasset, E., Bonan, S., Maiel, M., Bourget, I., Philippe, C., Herraiz Serrano, C., Benamar, S., Croce, O., et al. (2015) · Nature Communications · doi:10.1038/ncomms10204 · Cited by 367
‘Cancer associated fibroblasts’ – more than meets the eye
Madar, S., Goldstein, I., & Rotter, V. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.05.004 · Cited by 362
Hu, Y., Yan, C., Mu, L., Huang, K., Li, X., Tao, D., Wu, Y., & Qin, J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0125625 · Cited by 348
Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy?
Micke, P., & tman, A. (2004) · Lung Cancer · doi:10.1016/j.lungcan.2004.07.977 · Cited by 344
Fibrosis and cancer: Do myofibroblasts come also from epithelial cells via EMT?
Radisky, D. C., Kenny, P. A., & Bissell, M. J. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21186 · Cited by 344
Biomarker Expression and Risk of Subsequent Tumors After Initial Ductal Carcinoma In Situ Diagnosis
Kerlikowske, K., Molinaro, A. M., Gauthier, M. L., Berman, H. K., Waldman, F., Bennington, J., Sanchez, H., Jimenez, C., Stewart, K., Chew, K., et al. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq101 · Cited by 343
Self-citationTGF-beta in CAF-mediated tumor growth and metastasis
Calon, A., Tauriello, D. V. F., & Batlle, E. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.12.008 · Cited by 342
Interaction of tumor cells with the microenvironment
Ungefroren, H., Sebens, S., Seidl, D., Lehnert, H., & Hass, R. (2011) · Cell Communication and Signaling · doi:10.1186/1478-811x-9-18 · Cited by 333
Castells, M., Thibault, B., Delord, J.-P., & Couderc, B. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13089545 · Cited by 285
Qiu, W., Hu, M., Sridhar, A., Opeskin, K., Fox, S., Shipitsin, M., Trivett, M., Thompson, E. R., Ramakrishna, M., Gorringe, K. L., et al. (2008) · Nature Genetics · doi:10.1038/ng.117 · Cited by 282
Prognostic relevance of cancer-associated fibroblasts in human cancer
Paulsson, J., & Micke, P. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.02.006 · Cited by 275
Fibroblast heterogeneity and its implications for engineering organotypic skin models in vitro
Sriram, G., Bigliardi, P. L., & Bigliardi-Qi, M. (2015) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2015.08.001 · Cited by 269
Fibroblasts as architects of cancer pathogenesis
Marsh, T., Pietras, K., & McAllister, S. S. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.10.013 · Cited by 264
Martinez-Outschoorn, U. E., Pavlides, S., Howell, A., Pestell, R. G., Tanowitz, H. B., Sotgia, F., & Lisanti, M. P. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.01.023 · Cited by 248
Effective Immunoconjugate Therapy in Cancer Models Targeting a Serine Protease of Tumor Fibroblasts
Ostermann, E., Garin-Chesa, P., Heider, K. H., Kalat, M., Lamche, H., Puri, C., Kerjaschki, D., Rettig, W. J., & Adolf, G. R. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5211 · Cited by 246
Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation
Procopio, M.-G., Laszlo, C., Al Labban, D., Kim, D. E., Bordignon, P., Jo, S.-H., Goruppi, S., Menietti, E., Ostano, P., Ala, U., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3228 · Cited by 223
DeFilippis, R. A., Chang, H., Dumont, N., Rabban, J. T., Chen, Y.-Y., Fontenay, G. V., Berman, H. K., Gauthier, M. L., Zhao, J., Hu, D., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0107 · Cited by 212 · cited 7×
“…derived from breast tissues obtained from healthy women with high mammographic density (and no breast cancer) exhibit desmoplastic/protumorigenic phenotypes compared with fibroblasts derived from breast tissues obtained from women with lowmammographic density (DeFilippis et al. 2012, 2014).”
BackgroundInfluentialSelf-citationCaveolae and signalling in cancer
Martinez-Outschoorn, U. E., Sotgia, F., & Lisanti, M. P. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3915 · Cited by 211
Martinez-Outschoorn, U., Sotgia, F., & Lisanti, M. P. (2014) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.03.002 · Cited by 206
Schuberth, P. C., Hagedorn, C., Jensen, S. M., Gulati, P., van den Broek, M., Mischo, A., Soltermann, A., Jüngel, A., Marroquin Belaunzaran, O., Stahel, R., et al. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-187 · Cited by 206
Chen, H., Ruiz, P. D., McKimpson, W. M., Novikov, L., Kitsis, R. N., & Gamble, M. J. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.07.011 · Cited by 205
Mesenchymal stem cells in tumor development: Emerging roles and concepts
Cuiffo, B. G., & Karnoub, A. E. (2012) · Cell Adhesion & Migration · doi:10.4161/cam.20875 · Cited by 201
Tuxhorn, J. A., McAlhany, S. J., Yang, F., Dang, T. D., & Rowley, D. R. (2002) · PubMed · Cited by 195
Dumont, N., Liu, B., DeFilippis, R. A., Chang, H., Rabban, J. T., Karnezis, A. N., Tjoe, J. A., Marx, J., Parvin, B., & Tlsty, T. D. (2013) · Neoplasia · doi:10.1593/neo.121950 · Cited by 192
Self-citationBrennen, W. N., Rosen, D. M., Wang, H., Isaacs, J. T., & Denmeade, S. R. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs336 · Cited by 188
Pang, W., Su, J., Wang, Y., Feng, H., Dai, X., Yuan, Y., Chen, X., & Yao, W. (2015) · Cancer Science · doi:10.1111/cas.12747 · Cited by 183
Wang, H., Wu, Q., Liu, Z., Luo, X., Fan, Y., Liu, Y., Zhang, Y., Hua, S., Fu, Q., Zhao, M., et al. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.122 · Cited by 182
Izumi, D., Ishimoto, T., Miyake, K., Sugihara, H., Eto, K., Sawayama, H., Yasuda, T., Kiyozumi, Y., Kaida, T., Kurashige, J., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.29864 · Cited by 181
Carcinoma-Associated Fibroblasts Are a Promising Therapeutic Target
Togo, S., Polanska, U. M., Horimoto, Y., & Orimo, A. (2013) · Cancers · doi:10.3390/cancers5010149 · Cited by 178
MiR-21/Smad 7 signaling determines TGF-β1-induced CAF formation
Li, Q., Zhang, D., Wang, Y., Sun, P., Hou, X., Larner, J., Xiong, W., & Mi, J. (2013) · Scientific Reports · doi:10.1038/srep02038 · Cited by 176
Kinugasa, Y., Matsui, T., & Takakura, N. (2014) · Stem Cells · doi:10.1002/stem.1556 · Cited by 175
Servais, C., & Erez, N. (2012) · The Journal of Pathology · doi:10.1002/path.4103 · Cited by 173
Heterogeneity of stromal fibroblasts in tumor
Orimo, A., & Weinberg, R. A. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.4.4255 · Cited by 168
Saadi, A., Shannon, N. B., Lao-Sirieix, P., O’Donovan, M., Walker, E., Clemons, N. J., Hardwick, J. S., Zhang, C., Das, M., Save, V., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909797107 · Cited by 161
Mesenchymal stromal cells and fibroblasts: a case of mistaken identity?
Hematti, P. (2012) · Cytotherapy · doi:10.3109/14653249.2012.677822 · Cited by 158
Stroma in breast development and disease
Arendt, L. M., Rudnick, J. A., Keller, P. J., & Kuperwasser, C. (2009) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2009.10.003 · Cited by 148
Maris, P., Blomme, A., Palacios, A. P., Costanza, B., Bellahcène, A., Bianchi, E., Gofflot, S., Drion, P. V., Trombino, G. E., Valentin, E. D., et al. (2015) · PLoS Medicine · doi:10.1371/journal.pmed.1001871 · Cited by 147
Johansson, A., Ansell, A., Jerhammar, F., Lindh, M. B., Grenman, R. A., Munck‐Wikland, E., Östman, A., & Roberg, K. B. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0030 · Cited by 142
Perugorria, M. J., Wilson, C. L., Zeybel, M., Walsh, M. J., Amin, S., Robinson, S. M., White, S. A., Burt, A. D., Oakley, F., Tsukamoto, H., et al. (2012) · Hepatology · doi:10.1002/hep.25754 · Cited by 138
Vázquez, F., García-Ocaña, M., Galván, J. A., García–Martínez, J., García-Pravia, C., Menéndez‐Rodríguez, P., del Rey, C. G., Barneo, L., & Toyos, J. R. D. L. (2015) · Tumor Biology · doi:10.1007/s13277-015-3295-4 · Cited by 138
Perspective of Targeting Cancer-Associated Fibroblasts in Melanoma
Zhou, L., YANG, K. Y., Andl, T., Wickett, R. R., & Zhang, Y. (2015) · Journal of Cancer · doi:10.7150/jca.10865 · Cited by 135
IKKβ in intestinal mesenchymal cells promotes initiation of colitis-associated cancer
Koliaraki, V., Pasparakis, M., & Kollias, G. A. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20150542 · Cited by 134
Tanaka, K., Miyata, H., Sugimura, K., Fukuda, S., Kanemura, T., Yamashita, K., Miyazaki, Y., Takahashi, T., Kurokawa, Y., Yamasaki, M., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv067 · Cited by 132
Berdiel‐Acer, M., Pamplona, R. S., Calon, A., Cuadras, D., Berenguer, A., Sanjuán, X., Paúles, M. J., Salazar, R., Moreno, V. R., Batlle, E., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.04.006 · Cited by 130
Yuan, J., Liu, M., Yang, L., Tu, G., Zhu, Q., Chen, M., Cheng, H., Luo, H., Fu, W., Li, Z., et al. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0579-y · Cited by 128
The Prognostic Significance of Cancer-Associated Fibroblasts in Esophageal Squamous Cell Carcinoma
Ha, S. Y., Yeo, S.-Y., Xuan, Y.-H., & Kim, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099955 · Cited by 127
Senescent stroma promotes prostate cancer progression: The role of miR‐210
Taddei, M. L., Cavallini, L., Comito, G., Giannoni, E., Folini, M., Marini, A., Gandellini, P., Morandi, A., Pintus, G., Raspollini, M. R., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.07.009 · Cited by 127
Verghese, E. T., Drury, R. E., Green, C. A., Holliday, D. L., Lü, X., Nash, C. E., Speirs, V., Thorne, J. L., Thygesen, H. H., Zougman, A., et al. (2013) · The Journal of Pathology · doi:10.1002/path.4248 · Cited by 124
Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ
Sharma, M., Beck, A. H., Webster, J. A., Espinosa, Í., Montgomery, K. D., Varma, S., van de Rijn, M., Jensen, K. C., & West, R. B. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0654-0 · Cited by 120
Human breast cancer associated fibroblasts exhibit subtype specific gene expression profiles
Tchou, J. C., Kossenkov, A. V., Chang, L., Satija, C., Herlyn, M., Showe, L. C., & Puré, E. (2012) · BMC Medical Genomics · doi:10.1186/1755-8794-5-39 · Cited by 120
Peiris-Pagès, M., Sotgia, F., & Lisanti, M. P. (2015) · Oncotarget · doi:10.18632/oncotarget.3828 · Cited by 115
Understanding the metabolic basis of drug resistance
Martinez‐Outschoorn, U., Lin, Z., Ko, Y., Goldberg, A. F., Flomenberg, N., Wang, C., Pavlides, S., Pestell, R. G., Howell, A., Sotgia, F., et al. (2011) · Cell Cycle · doi:10.4161/cc.10.15.16584 · Cited by 111
The specification of feather and scale protein synthesis in epidermal-dermal recombinations
Dhouailly, D., Rogers, G. E., & Sengel, P. (1978) · Developmental Biology · doi:10.1016/0012-1606(78)90179-3 · Cited by 110
Kornmann, M., Ishiwata, T., Beger, H. G., & Korc, M. (1997) · Oncogene · doi:10.1038/sj.onc.1201307 · Cited by 107
Fischer, E., Chaitanya, K., Wüest, T., Wadle, A., Scott, A. M., van den Broek, M. F., Schibli, R., Bauer, S., & Renner, C. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0644 · Cited by 104
Osuala, K. O., Sameni, M., Shah, S., Aggarwal, N., Simonait, M. L., Franco, O. E., Hong, Y., Hayward, S. W., Behbod, F., Mattingly, R. R., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1576-3 · Cited by 103
Hendrayani, S., Al‐Khalaf, H. H., & Aboussekhra, A. (2013) · Neoplasia · doi:10.1593/neo.13478 · Cited by 99
New highlights on stroma–epithelial interactions in breast cancer
Barcellos‐Hoff, M. H., & Medina, D. (2004) · Breast Cancer Research · doi:10.1186/bcr972 · Cited by 98
Giulianelli, S., Cerliani, J. P., Lamb, C. A., Fabris, V. T., Bottino, M. C., Gorostiaga, M. A., Novaro, V., Góngora, A., Baldi, A., Molinolo, A., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23802 · Cited by 98
New insights into adipose tissue atrophy in cancer cachexia
Bing, C., & Trayhurn, P. (2009) · Proceedings of The Nutrition Society · doi:10.1017/s0029665109990267 · Cited by 96
Ohshio, Y., Teramoto, K., Hanaoka, J., Tezuka, N., Itoh, Y., Asai, T., Daigo, Y., & Ogasawara, K. (2014) · Cancer Science · doi:10.1111/cas.12584 · Cited by 95
Haubeiß, S., Schmid, J. O., Mürdter, T. E., Sonnenberg, M., Friedel, G., van der Kuip, H., & Aulitzky, W. E. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-168 · Cited by 94
Pennati, M., Lopergolo, A., Profumo, V., Cesare, M. D., Sbarra, S., Valdagni, R., Zaffaroni, N., Gandellini, P., & Folini, M. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.009 · Cited by 93
Kurashige, J., Mima, K., Sawada, G., Takahashi, Y., Eguchi, H., Sugimachi, K., Mori, M., Yanagihara, K., Yashiro, M., Hirakawa, K., et al. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu232 · Cited by 89
miR-205 Hinders the Malignant Interplay Between Prostate Cancer Cells and Associated Fibroblasts
Gandellini, P., Giannoni, E., Casamichele, A., Taddei, M. L., Callari, M., Piovan, C., Valdagni, R., Pierotti, M. A., Zaffaroni, N., & Chiarugi, P. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5292 · Cited by 88
Hypomethylating Therapy in an Aggressive Stroma-Rich Model of Pancreatic Carcinoma
Shakya, R., Gonda, T. A., Quante, M., Salas, M. C., Kim, S., Brooks, J. M., Hirsch, S., Davies, J. I., Cullo, A., Olive, K. P., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1880 · Cited by 85
Breast Carcinoma–Associated Fibroblasts Rarely Contain p53 Mutations or Chromosomal Aberrations
Hosein, A. N., Wu, M., Arcand, S. L., Lavallée, S., Hébert, J., Tonin, P. N., & Basik, M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0673 · Cited by 84
Doldi, V., Callari, M., Giannoni, E., D’Aiuto, F., Maffezzini, M., Valdagni, R., Chiarugi, P., Gandellini, P., & Zaffaroni, N. (2015) · Oncotarget · doi:10.18632/oncotarget.5056 · Cited by 74
Sadlonova, A., Bowe, D. B., Novák, Z., Mukherjee, S., Duncan, V. E., Page, G. P., & Frost, A. R. (2009) · Cancer Microenvironment · doi:10.1007/s12307-008-0017-0 · Cited by 73
Lin, H.-J. L., Zuo, T., Lin, C., Kuo, C. T., Liyanarachchi, S., Sun, S., Shen, R. Z., Deatherage, D. E., Potter, D., Asamoto, L., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0288 · Cited by 73
Cheng, N., Chytil, A., Shyr, Y., Joly, A. H., & Moses, H. L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3381 · Cited by 73
Lin, X., Jia, J.-S., Du, T., Li, W., Wang, X., Wei, J., Lin, X., Zeng, H., Yao, L., Chen, X.-B., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118417 · Cited by 72
Histone variant macroH2A1 deletion in mice causes female-specific steatosis
Boulard, M., Storck, S., Cong, R., Pinto, R. O., Delage, H., & Bouvet, P. (2010) · Epigenetics & Chromatin · doi:10.1186/1756-8935-3-8 · Cited by 67
Shah, S. H., Miller, P., García-Contreras, M., Ao, Z., Machlin, L., Issa, E., & El‐Ashry, D. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1071742 · Cited by 65
Platelet-derived Growth Factor Primes Cancer-associated Fibroblasts for Apoptosis
Ilyas, S. I., Mertens, J. C., Bronk, S. F., Hirsova, P., Dai, H., Roberts, L. R., Kaufmann, S. H., & Gores, G. J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.563064 · Cited by 63
Rozenchan, P. B., Carraro, D. M., Brentani, H., Mota, L. D. D. C., Bastos, E. P., Ferreira, E. N., Torres, C., Katayama, M. L. H., Roela, R. A., de Lyra, E. C., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24646 · Cited by 63
Gialeli, C., Nikitovic, D., Kletsas, D., Theocharis, A. D., Tzanakakis, G. N., & Karamanos, N. K. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990592 · Cited by 60
McDonald, L. T., Russell, D. L., Kelly, R. R., Xiong, Y., Motamarry, A., Patel, R. K., Jones, J. A., Watson, P. M., Turner, D. P., Watson, D. K., et al. (2015) · Neoplasia · doi:10.1016/j.neo.2015.04.004 · Cited by 59
HISTONE H3 MODIFICATIONS IN RAT HEPATIC STELLATE CELLS BY ETHANOL
KIM, J.-S., & Shukla, S. D. (2005) · Alcohol and Alcoholism · doi:10.1093/alcalc/agh170 · Cited by 58
Clinical Potential of MicroRNAs in Pancreatic Ductal Adenocarcinoma
Steele, C. W., Oien, K. A., McKay, C. J., & Jamieson, N. B. (2011) · Pancreas · doi:10.1097/mpa.0b013e3182218ffb · Cited by 52
Cell-extrinsic consequences of epithelial stress: activation of protumorigenic tissue phenotypes
Fordyce, C. A., Patten, K. T., Fessenden, T. B., DeFilippis, R., Hwang, E. S., Zhao, J., & Tlsty, T. D. (2012) · Breast Cancer Research · doi:10.1186/bcr3368 · Cited by 50
Self-citationRen, Y. T., Zhou, X., Liu, X., Jia, H.-H., Zhao, X., Wang, Q.-X., Han, L., Song, X., Zhu, Z.-Y., Sun, T., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.02.003 · Cited by 48
Mitchell, C., Park, M. A., Zhang, G., Han, S. I., Harada, H., Franklin, R. A., Yacoub, A., Li, P., Hylemon, P. B., Grant, S., et al. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0532 · Cited by 47
Kang, N., Shah, V. H., & Urrutia, R. A. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0542 · Cited by 47
A reciprocal role of prostate cancer on stromal DNA damage
Banerjee, J., Mishra, R., Li, X., Jackson, R. S., Sharma, A., & Bhowmick, N. A. (2013) · Oncogene · doi:10.1038/onc.2013.431 · Cited by 45
The cancer-associated fibroblasts and drug resistance.
Xy, L., Sq, H., & Xiao, L. (2015) · PubMed · Cited by 42
Lecomte, J., Masset, A., Blacher, S., Maertens, L., Gothot, A., Delgaudine, M., Bruyére, F., Carnet, O., Paupert, J., Illemann, M., et al. (2012) · Neoplasia · doi:10.1593/neo.121092 · Cited by 41
Fordyce, C., Fessenden, T., Pickering, C., Jung, J., Singla, V., Berman, H., & Tlsty, T. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0229 · Cited by 41
Self-citationDeFilippis, R. A., Fordyce, C., Patten, K. T., Chang, H., Zhao, J., Fontenay, G., Kerlikowske, K. M., Parvin, B., & Tlsty, T. D. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3390 · Cited by 38
Self-citationChou, J., & Werb, Z. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0465 · Cited by 38
Tumor microenvironment in invasive lobular carcinoma: possible therapeutic targets
Nakagawa, S., Miki, Y., Miyashita, M., Hata, S., Takahashi, Y., Rai, Y., Sagara, Y., Ohi, Y., Hirakawa, H., Tamaki, K., et al. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3668-9 · Cited by 37
Wagner, E. F. (2016) · Nature · doi:10.1038/530042a · Cited by 37
Ruscetti, F. W., Birchenall-Roberts, M. C., McPherson, J. M., & Wiltrout, R. H. (1998) · Elsevier eBooks · doi:10.1016/b978-012498340-3/50029-4 · Cited by 35
CAF reprogramming inhibits ovarian cancer progression
Yeung, T.-L., Leung, C. S., & Mok, S. C. (2014) · Cell Cycle · doi:10.4161/15384101.2014.988106 · Cited by 27
Corver, W. E., ter Haar, N. T., Fleuren, G. J., & Oosting, J. (2011) · Cellular Oncology · doi:10.1007/s13402-011-0061-5 · Cited by 26
Targeting breast cancer-associated fibroblasts to improve anti-cancer therapy
Slany, A., Bileck, A., Muqaku, B., & Gerner, C. (2015) · The Breast · doi:10.1016/j.breast.2015.06.009 · Cited by 25
Clinical Activity, Toxicity, Biomarkers, and Future Development of CTLA-4 Checkpoint Antagonists
Callahan, M. K., & Wolchok, J. D. (2015) · Seminars in Oncology · doi:10.1053/j.seminoncol.2015.05.008 · Cited by 23
Review of Cancer – Associated Fibroblasts and Therapies that Interfere with Their Activity
Takebe, N., Ivy, P. S., Timmer, W. C., Khan, N. I., Schulz, T., & Harris, P. J. (2013) · Tumor Microenvironment and Therapy · doi:10.2478/tumor-2013-0001 · Cited by 17
Tumor microenvironment: the promising target for tumor therapy
(2014) · Cancer Cell & Microenvironment · doi:10.14800/ccm.81 · Cited by 2
Cited by
Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer
Costa, A., Kieffer, Y., Scholer-Dahirel, A., Pelon, F., Bourachot, B., Cardon, M., Sirven, P., Magagna, I., Fuhrmann, L., Bernard, C., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.01.011 · Cited by 1,705
Lindner, T., Loktev, A., Altmann, A., Giesel, F., Kratochwil, C., Debus, J., Jäger, D., Mier, W., & Haberkorn, U. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.210443 · Cited by 935
Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy
Liu, T., Han, C., Wang, S., Fang, P., Ma, Z., Xu, L., & Yin, R. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0770-1 · Cited by 860
In search of definitions: Cancer‐associated fibroblasts and their markers
Nurmik, M., Ullmann, P., Rodriguez, F., Haan, S., & Letellier, E. (2020) · International Journal of Cancer · doi:10.1002/ijc.32193 · Cited by 739
The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses
Labani-Motlagh, A., Ashja-Mahdavi, M., & Loskog, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00940 · Cited by 751
Metadata
- Authors
- Gascard, P., & Tlsty, T. D.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2016-05-01
- Volume
- 30
- Issue
- 9
- Pages
- 1002-1019
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2347175105
- Cited by
- 732
- References
- 142
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.